Acne flare-up during the first month of treatment with oral isotretinoin is a recognized phenomenon. To avoid a flare, starting treatment with a daily dose of no more than 0.5 mg/kg is recommended. The purpose of this observational study was to assess if starting daily doses lower than 0.5 mg/kg can further reduce the occurrence of flares during the first month of isotretinoin administration. One hundred thirty-two acne patients receiving an initial daily dose ≤ 0.2 mg/kg were retrospectively compared with 142 patients treated with a starting dose of 0.5 mg/kg/day. In both groups, the dosage was progressively increased until the highest tolerated dose ≤ 1 mg/kg. A significantly lower incidence (p=0.0415) of flare during the first 4 weeks of treatment was found in patients who started isotretinoin at a daily dose ≤ 0.2 mg/kg compared with patients receiving 0.5 mg/kg. Based on these findings, initial doses of less than 0.5 mg/kg/day may potentially reduce acute acne flare occurrence and its related distress.

Acute acne flare following isotretinoin administration: potential protective role of low starting dose

BORGHI, Alessandro;MANTOVANI, Lucia;MINGHETTI, Sara;VIRGILI, Anna;
2009

Abstract

Acne flare-up during the first month of treatment with oral isotretinoin is a recognized phenomenon. To avoid a flare, starting treatment with a daily dose of no more than 0.5 mg/kg is recommended. The purpose of this observational study was to assess if starting daily doses lower than 0.5 mg/kg can further reduce the occurrence of flares during the first month of isotretinoin administration. One hundred thirty-two acne patients receiving an initial daily dose ≤ 0.2 mg/kg were retrospectively compared with 142 patients treated with a starting dose of 0.5 mg/kg/day. In both groups, the dosage was progressively increased until the highest tolerated dose ≤ 1 mg/kg. A significantly lower incidence (p=0.0415) of flare during the first 4 weeks of treatment was found in patients who started isotretinoin at a daily dose ≤ 0.2 mg/kg compared with patients receiving 0.5 mg/kg. Based on these findings, initial doses of less than 0.5 mg/kg/day may potentially reduce acute acne flare occurrence and its related distress.
Borghi, Alessandro; Mantovani, Lucia; Minghetti, Sara; Virgili, Anna; Bettoli, V.
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11392/533134
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 31
  • ???jsp.display-item.citation.isi??? 27
social impact